-Nancy A Thornberry Researcher Activity Profile

Research Author Detailed Information 

Nancy A Thornberry Publication Rate By Year

Nancy A Thornberry has published 8 paper(s) in 2007, 4 paper(s) in 2008, for a total of 12 research publications in total.

Nancy A Na Thornberry Author Information

LAST NAME: thornberry

FIRST NAME: Nancy A

INITIALS: na

AFFILIATION:

Papers

Nancy A Thornberry's Publication Record

1. Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway. Year Published: 2007
Departments of Medicine, Cell Biology, and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. lcr@jhmi.edu
2. Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors. Year Published: 2007
Merck Research Laboratories, Department of Medicinal Chemistry, PO Box 2000, Rahway, NJ 07065, USA. jason_cox@merck.com
3. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. jennifer_kowalchick@yahoo.com
4. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. david_kaelin@merck.com
5. Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. ping_chen@merck.com
6. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. jennifer_kowalchick@yahoo.com
7. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. david_kaelin@merck.com
8. Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. ping_chen@merck.com
9. Discovery of Potent and Selective Dipeptidyl Peptidase IV Inhibitors Derived from beta-Aminoamides Bearing Subsituted Triazolopiperazines. Year Published: 2008
dooseop_kim@merck.com.
10. Identification of glucose-dependant insulin secretion targets in pancreatic beta cells by combining defined-mechanism compound library screening and siRNA gene silencing. Year Published: 2008
Merck & Co Inc, Target Validation, Merck Research Laboratory, Rahway, NJ 07065, USA.
11. Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Year Published: 2008
Department of Medicinal Chemistry, Merck & Co. Inc., PO Box 2000, Rahway, NJ 07065, USA. scott_edmondson@merck.com
12. Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Year Published: 2008
Department of Medicinal Chemistry, Merck & Co. Inc., PO Box 2000, Rahway, NJ 07065, USA. scott_edmondson@merck.com